ArticleOncotarget2016

Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy.

Corinne Renier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.